Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lokker ME, van Zuylen L, van der Rijt CC, et al. Prevalence, impact, and treatment of death rattle: a systematic review. J Pain Symptom Manage. 2014;47(1):105–22.
Kolb H, Snowden A, Stevens E. Systematic review and narrative summary: treatments for and risk factors associated with respiratory tract secretions (death rattle) in the dying adult. J Adv Nurs. 2018;74(7):1446–62.
Campbell ML, Yarandi HN. Death rattle is not associated with patient respiratory distress: is pharmacologic treatment indicated? J Palliat Med. 2014;16(10):1255–9.
National Institute for Health and Care Excellence. Palliative care: secretions. 2021. https://www.nice.org.uk/cks-uk-only. Accessed 5 Oct 2022.
Bennett M, Lucas V, Brennan M, et al. Using anti-muscarinic drugs in the management of death rattle: evidence-based guidelines for palliative care. Palliat Med. 2002;16(5):369–74.
van Esch HJ, van Zuylen L, Geijteman E, et al. Effect of prophylactic subcutaneous scopolamine butylbromide on death rattle in patients at the end of life: the SILENCE Randomized Clinical Trial. JAMA. 2021;326(13):1268–76.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Parker-Smith, J., Corbett, C. (2023). Approach to Respiratory Secretions at the End of Life. In: Junckerstorff, R., Brady, S., Aung, A.K. (eds) Beyond Evidence-Based Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-99-4440-8_30
Download citation
DOI: https://doi.org/10.1007/978-981-99-4440-8_30
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-4439-2
Online ISBN: 978-981-99-4440-8
eBook Packages: MedicineMedicine (R0)